Dr. Reddy's Laboratories Share Price Today
(NASDAQ: RDY)

Name: Dr. Reddy's Laboratories Share Price Today (NASDAQ: RDY) - Dr. Reddy's Laboratories Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Dr. Reddy's Laboratories share price is $13.35 & ₹1,157.79 as on 22 Feb 2025, 2.30 'hrs' IST

$13.35

▲

-0.09

(-0.67%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Dr. Reddy's Laboratories share price in Dollar and Rupees. Guide to invest in Dr. Reddy's Laboratories stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dr. Reddy's Laboratories, along with analyst recommendations, forecasts, and comprehensive financials.

Dr. Reddy's Laboratories share price movements

Today's Low: $13.19
Today's High: $13.35
$13.35
1.2%
Downside
Day's Volatility :1.2%
Upside
0.0%
52 Weeks Low: $13.16
52 Weeks High: $16.89
$13.35
1.42%
Downside
52 Weeks Volatility :22.09%
Upside
20.97%

Dr. Reddy's Laboratories (RDY) Returns

Period	Dr. Reddy's Laboratories Ltd.	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.77%	1.6%	0.0%
6 Months	-18.99%	-5.8%	0.0%
1 Year	-13.41%	-1.0%	0.0%
3 Years	20.21%	15.7%	-9.0%

Dr. Reddy's Laboratories (RDY) Key Statistics

in dollars & INR

Previous Close	$13.44
Open	$13.26
Today's High	$13.35
Today's Low	$13.19
Market Capitalization	$11.2B
Today's Volume	$1.5M
52 Week High	$16.892
52 Week Low	$13.16
Revenue TTM	$311.3B
EBITDA	$85.6B
Earnings Per Share (EPS)	$0.74
PE Ratio	18.16
Dividend Yield	0.71%
Profit Margin	17.24%
Quarterly Earnings Growth YOY	0.02%
Return On Equity TTM	18.47%

How to invest in Dr. Reddy's Laboratories Stock (RDY) from India?

It is very easy for Indian residents to invest directly in Dr. Reddy's Laboratories from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dr. Reddy's Laboratories stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dr. Reddy's Laboratories or RDY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dr. Reddy's Laboratories or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dr. Reddy's Laboratories shares which would translate to 0.065 fractional shares of Dr. Reddy's Laboratories as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dr. Reddy's Laboratories, in just a few clicks!

Returns in Dr. Reddy's Laboratories (RDY) for Indian investors in Rupees

The Dr. Reddy's Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Dr. Reddy's Laboratories investment value today

Current value as on today

₹91,225

Returns

₹8,775

(-8.77%)

Returns from Dr. Reddy's Laboratories Stock

₹13,424 (-13.42%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Dr. Reddy's Laboratories (RDY)

20.35%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Investment in Dr. Reddy's Laboratories Shares from India has grown by 20.35% over the past 30 days, indicating increased transactional activity.

68%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Search interest for Dr. Reddy's Laboratories Stock from India on INDmoney has increased by 68% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dr. Reddy's Laboratories

Robeco Institutional Asset Management BV
1.37%
Morgan Stanley - Brokerage Accounts
1.35%
Royal Bank of Canada
1.20%
Renaissance Technologies Corp
1.17%
BlackRock Inc
1.15%
Aikya Investment Management Ltd
0.67%

Analyst Recommendation on Dr. Reddy's Laboratories

Buy

42%Buy

30%Hold

27%Sell

Based on 40 Wall street analysts offering stock ratings for Dr. Reddy's Laboratories(by analysts ranked 0 to 5 stars)

Based on 40 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Dr. Reddy's Laboratories Stock (RDY)

What analysts predicted

Upside of 16.6%

Target:

$15.57

Current:

$13.35

Insights on Dr. Reddy's Laboratories Stock (Ticker Symbol: RDY)

Price Movement
In the last 6 months, RDY stock has moved down by -18.8%
Increasing Revenue
Revenue is up for the last 8 quarters, 62.96B → 83.58B (in $), with an average increase of 3.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 12.55B → 14.13B (in $), with an average increase of 11.2% per quarter
RDY vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 83.3% return, outperforming this stock by 97.3%
RDY vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 142.4% return, outperforming this stock by 122.1%
Price to Sales
ForRDY every $1 of sales, investors are willing to pay $0.2, whereas for Intra-cellular Therapies, Inc., the investors are paying $21.1 for every $1 of sales.

RDY Dr. Reddy's Laboratories Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.2B	↑ 8.32%
Net Income	$269.6M	↑ 91.67%
Net Profit Margin	12.22%	↑ 5.32%

	FY20	Y/Y Change
Revenue	$2.3B	↑ 13.49%
Net Income	$261.4M	↑ 3.74%
Net Profit Margin	11.17%	↓ 1.05%

	FY21	Y/Y Change
Revenue	$2.6B	↑ 8.66%
Net Income	$236.7M	↓ 11.59%
Net Profit Margin	9.09%	↓ 2.08%

	FY22	Y/Y Change
Revenue	$2.8B	↑ 13.0%
Net Income	$309.2M	↑ 36.72%
Net Profit Margin	10.99%	↑ 1.9%

	FY23	Y/Y Change
Revenue	$3.0B	↑ 14.69%
Net Income	$548.0M	↑ 91.22%
Net Profit Margin	18.33%	↑ 7.34%

	FY24	Y/Y Change
Revenue	$3.4B	↑ 13.54%
Net Income	$670.6M	↑ 23.56%
Net Profit Margin	19.95%	↑ 1.62%

	Q3 FY23	Q/Q Change
Revenue	$828.4M	↑ 2.1%
Net Income	$178.2M	↑ 5.53%
Net Profit Margin	21.51%	↑ 0.7%

	Q4 FY23	Q/Q Change
Revenue	$866.6M	↑ 4.86%
Net Income	$165.6M	↓ 6.83%
Net Profit Margin	19.11%	↓ 2.4%

	Q1 FY24	Q/Q Change
Revenue	$924.0M	↑ 6.35%
Net Income	$167.6M	↑ 0.95%
Net Profit Margin	18.14%	↓ 0.97%

	Q2 FY24	Q/Q Change
Revenue	$919.1M	↑ 0.0%
Net Income	$166.8M	↑ 0.0%
Net Profit Margin	18.14%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$80.2B	↑ 4.48%
Net Income	$12.6B	↓ 9.82%
Net Profit Margin	15.66%	↓ 2.48%

	Q4 FY24	Q/Q Change
Revenue	$83.6B	↑ 4.27%
Net Income	$14.1B	↑ 12.59%
Net Profit Margin	16.91%	↑ 1.25%

	FY19	Y/Y Change
Profit	$1.2B	↑ 9.34%

	FY20	Y/Y Change
Profit	$1.3B	↑ 12.68%

	FY21	Y/Y Change
Profit	$1.4B	↑ 9.65%

	FY22	Y/Y Change
Profit	$1.5B	↑ 10.44%

	FY23	Y/Y Change
Profit	$2.5B	↑ 78.3%

	FY24	Y/Y Change
Profit	$2.0B	↓ 19.39%

	Q3 FY23	Q/Q Change
Profit	$486.0M	↑ 2.06%

	Q4 FY23	Q/Q Change
Profit	$506.9M	↑ 4.55%

	Q1 FY24	Q/Q Change
Profit	$558.1M	↑ 9.81%

	Q2 FY24	Q/Q Change
Profit	$555.2M	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$47.8B	↑ 3.07%

	Q4 FY24	Q/Q Change
Profit	$49.1B	↑ 2.69%

	FY19	Y/Y Change
Operating Cash Flow	$411.8M	↑ 59.21%
Investing Cash Flow	$-110.9M	↓ 48.08%
Financing Cash Flow	$-306.0M	↑ 380.32%

	FY20	Y/Y Change
Operating Cash Flow	$400.0M	↑ 3.96%
Investing Cash Flow	$-66.0M	↓ 36.29%
Financing Cash Flow	$-337.2M	↑ 17.97%

	FY21	Y/Y Change
Operating Cash Flow	$490.2M	↑ 19.64%
Investing Cash Flow	$-311.1M	↑ 360.29%
Financing Cash Flow	$-4.1M	↓ 98.82%

	FY22	Y/Y Change
Operating Cash Flow	$368.8M	↓ 21.27%
Investing Cash Flow	$-346.2M	↑ 16.45%
Financing Cash Flow	$-31.8M	↑ 712.75%

	FY23	Y/Y Change
Operating Cash Flow	$715.9M	↑ 109.45%
Investing Cash Flow	$-503.1M	↑ 56.79%
Financing Cash Flow	$-326.6M	↑ 1009.04%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$215.8M	↑ 59.34%
Investing Cash Flow	$-153.6M	↑ 182.33%
Financing Cash Flow	$-84.7M	↑ 376.69%

Dr. Reddy's Laboratories Technicals Summary

Sell

Neutral

Buy

Dr. Reddy's Laboratories is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Dr. Reddy's Laboratories (RDY) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dr. Reddy's Laboratories Ltd.	-4.71%	-18.99%	-13.41%	20.21%	54.94%
Intra-cellular Therapies, Inc.	1.09%	72.64%	79.71%	132.63%	478.24%
Haleon Plc Spon Ads	7.35%	2.13%	21.89%	36.03%	36.03%
Zoetis Inc.	-4.83%	-11.62%	-18.56%	-17.59%	17.86%
Neurocrine Biosciences Inc.	-18.85%	-20.74%	-10.98%	35.82%	28.46%
Viatris Inc.	0.45%	-4.26%	-16.23%	-22.63%	-31.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dr. Reddy's Laboratories Ltd.	18.16	18.16	4.51	68.82	0.18	0.1	0.01	381.36
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.71	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	30.55	30.55	1.73	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	29.39	29.39	2.78	6.14	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	36.68	36.68	0.27	6.46	0.14	0.1	NA	26.05
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dr. Reddy's Laboratories Ltd.	Buy	$11.2B	54.94%	18.16	17.24%
Intra-cellular Therapies, Inc.	Buy	$13.7B	478.24%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$45.6B	36.03%	30.55	10.75%
Zoetis Inc.	Buy	$71.9B	17.86%	29.39	26.86%
Neurocrine Biosciences Inc.	Buy	$12.0B	28.46%	36.68	14.49%
Viatris Inc.	Hold	$13.2B	-31.15%	224.4	-5.87%

Dr. Reddy's Laboratories Dividend announcements

Dr. Reddy's Laboratories Dividends September, 2024
In the quarter ending September,2024. Dr. Reddy's Laboratories has declared dividend of $0.48
Read More

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in Hyderabad, Telangana, India. Founded in 1984 by Dr. K. Anji Reddy, the company provides a wide range of pharmaceuticals in India and over 25 countries worldwide. Dr. Reddy's Laboratories operates in various segments, including generic medicines, active pharmaceutical ingredients (APIs), custom pharmaceutical services, biosimilars, and differentiated formulations. The company's portfolio includes products for therapeutic areas such as gastroenterology, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy's Laboratories is listed on the NYSE under the ticker symbol RDY, making its American Depositary Receipts (ADRs) available to U.S. investors. Known for its commitment to innovation, quality, and affordability, Dr. Reddy's Laboratories continues to deliver comprehensive healthcare solutions and improve the lives of patients globally. Currently Dr. Reddy's Laboratories ADR has a market cap of $13.73 Billion. It has a P.E ratio of 0.0. The shares of Dr. Reddy's Laboratories ADR are trading at $13.35 .

Organization	Dr. Reddy's Laboratories
Employees	27048
CEO	Mr. Patrick Aghanian B.A., M.B.A.
Industry	Health Technology

Management People of Dr. Reddy's Laboratories

Name	Title
Mr. Gunupati Venkateswara Prasad B.E.	Co-Chairman, MD & Member of Management Council
Mr. Kallam Satish Reddy B.Tech., M.S.	Chairman of the Board & Member of the Management Council
Mr. Erez Israeli M.B.A.	CEO & Member of the Management Council
Mr. Mannam Venkatanarasimham	CFO & Member of the Management Council
Mr. Krishna K. Venkatesh B.Pharma M.S.	Global Head of Quality and Pharmacovigilance & Member of the Management Council
Mr. Deepak Sapra M.B.A.	CEO of API & Services & Member of Management Council
Mr. Venkata Ramana Motupalli M.B.A.	CEO of Branded Markets - India & Emerging Countries and Member of Management Council
Ms. Archana Bhaskar B.Sc., M.B.A.	EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council
Mr. Sanjay Sharma B.Tech.	Executive VP, Global Head of Global Manufacturing & Member of Management Council
Mr. Patrick Aghanian B.A., M.B.A.	CEO of European Generics & Member of Management Council

Important FAQs about investing in RDY Stock from India :

What is Dr. Reddy's Laboratories share price today?

Dr. Reddy's Laboratories share price today stands at $13.35, Open: $13.26 ; Previous Close: $13.44 ; High: $13.35 ; Low: $13.19 ; 52 Week High: $16.89 ; 52 Week Low: $13.16.

The stock opens at $13.26, after a previous close of $13.44. The stock reached a daily high of $13.35 and a low of $13.19, with a 52-week high of $16.89 and a 52-week low of $13.16.

Can Indians buy Dr. Reddy's Laboratories shares?

Yes, Indians can invest in the Dr. Reddy's Laboratories (RDY) from India.

With INDmoney, you can buy Dr. Reddy's Laboratories at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dr. Reddy's Laboratories at zero transaction cost.

How can I buy Dr. Reddy's Laboratories shares from India?

It is very easy to buy Dr. Reddy's Laboratories from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dr. Reddy's Laboratories (RDY) be purchased?

Yes, you can buy fractional shares of Dr. Reddy's Laboratories with INDmoney app.

What are the documents required to start investing in Dr. Reddy's Laboratories stocks?

To start investing in Dr. Reddy's Laboratories, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.